Medicilon Revenue and Competitors

Pudong,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Medicilon's estimated annual revenue is currently $47.4M per year.(i)
  • Medicilon's estimated revenue per employee is $155,000

Employee Data

  • Medicilon has 306 Employees.(i)
  • Medicilon grew their employee count by 3% last year.

Medicilon's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Medicilon?

Shanghai Medicilon Inc was founded in 2004 with the explicit purpose of providing fully integrated pharmaceutical research and development to the global pharmaceutical community. To provide the best service Shanghai Medicilon Inc. is organized in three departments: biology, chemistry and preclinical through Medicilon/MPI. In this way the company has the ability to provide specific services in each sector, and at the same time, competences from the other departments to provide fully integrated services. Shanghai Medicilon Inc has been recognized as one of the top drug discovery contract research organizations in China and is managed by a team of scientists with many years of experience in US-based pharmaceutical and biotechnology companies. Shanghai Medicilon Inc has a strictly professional research team, with over 1000 scientists. We have expertise, experience and resources to devise, implement, and support all your research needs. We take pride in maintaining an open dialogue with our customers and upholding our commitments to intellectual property protection and client confidentiality. In this way we're always able to deliver a neutral and professional research for our clients. As our areas of expertise and service capabilities continue to expand, major pharmaceutical and biotechnology companies from across 4 continents have taken advantage of our integrated drug discovery and development services.

keywords:N/A

N/A

Total Funding

306

Number of Employees

$47.4M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medicilon News

2022-04-20 - In Vitro ADME Testing Services Market In-Depth Analysis ...

... Evotec, Galapagos, Tecan Group, GVK Biosciences, Pharmaron, Sai Life Sciences, Shanghai Medicilon, Syngene International, WuXi AppTec.

2022-04-17 - Ligand Binding Assay Market Size, Share, Forecast 2022-2029| Key ...

Shanghai Medicilon Inc; Intertek Group plc; PerkinElmer Inc; Charles River; Alliance Pharma; Eurofins Discovery; Creative Biogene; IBR Inc; LGC...

2022-04-17 - Global Preclinical Magnetic Particle Imaging (MPI) Market 2022 ...

Medicilon, Bruker Corporation, Mediso, Magnetic Insight – Bloomingprairieonline...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$251.7M12842%$315M